Calidi Biotherapeutics, Inc., a biotechnology company specializing in biological products, has increased its stock offering capacity under its existing Sales Agreement with Ladenburg Thalmann & Co.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

BofA Securities has recently resumed NiSource Inc (NI) stock to Buy rating, as announced on September 12, 2024, according to Finviz. Earlier, on July 11, 2024, Mizuho had initiated the stock to ...

Ladenburg Thalmann has recently raised Evaxion Biotech A S ADR Representing 10 Ord Shs (EVAX) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Analyst ratings are significant ...